Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John M. Capek currently holds 339,443 shares of ABBOTT LABORATORIES (ABT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John M. Capek has been a net seller of ABT stock. They have purchased $0 and sold $52.8M worth of shares.
John M. Capek's most recent insider trade was on Feb 28, 2023, when they sold 6,247 shares at $99.77 per share.
John M. Capek serves as Executive at ABBOTT LABORATORIES (ABT). They have executed 152 insider transactions totaling $52.8M over their tenure at the company.
John M. Capek holds the position of Executive at ABBOTT LABORATORIES, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
John M. Capek has shown a selling trading pattern, with $0 in total purchases and $52.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John M. Capek was on Dec 13, 2021, when they sold $20.2M worth of ABT shares. This transaction involved 149,600 shares at $135.05 per share.
John M. Capek currently owns 339,443 shares of ABBOTT LABORATORIES (ABT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John M. Capek's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John M. Capek has 152 Form 4 filings on record as an insider at ABBOTT LABORATORIES.
Set alerts for John M. Capek and 40,000+ other insiders.